163 related articles for article (PubMed ID: 35541758)
21. Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases.
McGillewie L; Ramesh M; Soliman ME
Protein J; 2017 Oct; 36(5):385-396. PubMed ID: 28762197
[TBL] [Abstract][Full Text] [Related]
22. Targeting Plasmodium Proteases to Block Malaria Parasite Escape and Entry.
Paul AS; Duraisingh MT
Trends Parasitol; 2018 Feb; 34(2):95-97. PubMed ID: 29269028
[TBL] [Abstract][Full Text] [Related]
23. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
Gutiérrez-de-Terán H; Nervall M; Ersmark K; Liu P; Janka LK; Dunn B; Hallberg A; Aqvist J
Biochemistry; 2006 Sep; 45(35):10529-41. PubMed ID: 16939205
[TBL] [Abstract][Full Text] [Related]
24. Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review.
Kumi RO; Oti B; Abo-Dya NE; Alahmdi MI; Soliman MES
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432016
[TBL] [Abstract][Full Text] [Related]
25. Flap Dynamics in Aspartic Proteases: A Computational Perspective.
Mahanti M; Bhakat S; Nilsson UJ; Söderhjelm P
Chem Biol Drug Des; 2016 Aug; 88(2):159-77. PubMed ID: 26872937
[TBL] [Abstract][Full Text] [Related]
26. Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.
Rawat M; Vijay S; Gupta Y; Dixit R; Tiwari PK; Sharma A
Infect Genet Evol; 2011 Jul; 11(5):924-33. PubMed ID: 21382523
[TBL] [Abstract][Full Text] [Related]
27. Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites.
Ponsuwanna P; Kochakarn T; Bunditvorapoom D; Kümpornsin K; Otto TD; Ridenour C; Chotivanich K; Wilairat P; White NJ; Miotto O; Chookajorn T
Malar J; 2016 Jan; 15():51. PubMed ID: 26821618
[TBL] [Abstract][Full Text] [Related]
28. A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.
Pino P; Caldelari R; Mukherjee B; Vahokoski J; Klages N; Maco B; Collins CR; Blackman MJ; Kursula I; Heussler V; Brochet M; Soldati-Favre D
Science; 2017 Oct; 358(6362):522-528. PubMed ID: 29074775
[TBL] [Abstract][Full Text] [Related]
29. Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.
Mukherjee B; Tessaro F; Vahokoski J; Kursula I; Marq JB; Scapozza L; Soldati-Favre D
EMBO J; 2018 Apr; 37(7):. PubMed ID: 29519896
[No Abstract] [Full Text] [Related]
30. An Endoplasmic Reticulum CREC Family Protein Regulates the Egress Proteolytic Cascade in Malaria Parasites.
Fierro MA; Asady B; Brooks CF; Cobb DW; Villegas A; Moreno SNJ; Muralidharan V
mBio; 2020 Feb; 11(1):. PubMed ID: 32098818
[TBL] [Abstract][Full Text] [Related]
31. Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.
Ersmark K; Feierberg I; Bjelic S; Hamelink E; Hackett F; Blackman MJ; Hultén J; Samuelsson B; Aqvist J; Hallberg A
J Med Chem; 2004 Jan; 47(1):110-22. PubMed ID: 14695825
[TBL] [Abstract][Full Text] [Related]
32. A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility.
Kumalo HM; Soliman ME
J Recept Signal Transduct Res; 2016 Oct; 36(5):505-14. PubMed ID: 26804314
[TBL] [Abstract][Full Text] [Related]
33. Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
Kumar Singh A; Rajendran V; Singh S; Kumar P; Kumar Y; Singh A; Miller W; Potemkin V; Poonam ; Grishina M; Gupta N; Kempaiah P; Durvasula R; Singh BK; Dunn BM; Rathi B
Bioorg Med Chem; 2018 Jul; 26(13):3837-3844. PubMed ID: 29983285
[TBL] [Abstract][Full Text] [Related]
34.
Sharma PP; Kumar S; Kaushik K; Singh A; Singh IK; Grishina M; Pandey KC; Singh P; Potemkin V; Poonam ; Singh G; Rathi B
J Biomol Struct Dyn; 2022 Nov; 40(18):8352-8364. PubMed ID: 33870856
[TBL] [Abstract][Full Text] [Related]
35. Molecular Dynamics Simulations of Ligand-Induced Flap Conformational Changes in Cathepsin-D-A Comparative Study.
Arodola OA; Soliman ME
J Cell Biochem; 2016 Nov; 117(11):2643-57. PubMed ID: 27038253
[TBL] [Abstract][Full Text] [Related]
36. Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway.
Rathore I; Mishra V; Patel C; Xiao H; Gustchina A; Wlodawer A; Yada RY; Bhaumik P
FEBS J; 2021 Jan; 288(2):678-698. PubMed ID: 32385863
[TBL] [Abstract][Full Text] [Related]
37. New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.
Dan N; Bhakat S
Eur J Med Chem; 2015 May; 95():324-48. PubMed ID: 25827401
[TBL] [Abstract][Full Text] [Related]
38. Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D.
Martins LS; Kruger HG; Naicker T; Alves CN; Lameira J; Araújo Silva JR
RSC Adv; 2022 Dec; 13(1):602-614. PubMed ID: 36605626
[TBL] [Abstract][Full Text] [Related]
39. The Actinomyosin Motor Drives Malaria Parasite Red Blood Cell Invasion but Not Egress.
Perrin AJ; Collins CR; Russell MRG; Collinson LM; Baker DA; Blackman MJ
mBio; 2018 Jul; 9(4):. PubMed ID: 29970464
[TBL] [Abstract][Full Text] [Related]
40. Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target.
Ramírez AR; Guerra Y; Otero A; García B; Berry C; Mendiola J; Hernández-Zanui A; Chávez Mde L
Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):149-57. PubMed ID: 18471091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
